
[TOP STORY] Ultra-rare disease costs threaten sustainability of SA medical schemes
Loading player...
‘For smaller schemes, you find that some of them rarely collect contributions in excess of R50 million per year. If they were to fund treatment for one of these diseases, it then becomes a very big portion of what is actually collected,’ says Charlton Murove, head of research at the Board of Healthcare Funders.